{
  "ticker": "TGH",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965649",
  "id": "02965649",
  "pages": 1,
  "price_sensitive": true,
  "date": "20250703",
  "time": "1412",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250703/pdf/06lfh0hgh0bkk0.pdf",
  "summary": "- **US Patent Granted**: Patent US 12,329,181 B2 issued for microbial feed supplement (Terragen Probiotic for Ruminants\u2122 and MYLO\u00ae), expiring 27 March 2041.  \n- **Market Impact**: Strengthens IP protection in the US, a key target market, supporting regulatory approvals for US launch.  \n- **Valuation Relevance**: Enhances competitive position in global animal probiotics market; extends commercial exclusivity until 2041.  \n\n(No other material trading or capital markets information identified.)",
  "usage": {
    "prompt_tokens": 805,
    "completion_tokens": 112,
    "total_tokens": 917,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T05:36:29.998751"
}